Hong Kong-listed innovative drug stocks continued their upward trend, with WuXi AppTec (02359.HK) rising over 12%, BeiGene (06160.HK) rising over 10%, and other companies such as Akeso Biopharma (09926.HK) and Simcere Pharmaceutical (02096.HK) following suit.